{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,4]],"date-time":"2026-11-04T23:56:05Z","timestamp":1793836565222,"version":"4.6.1"},"reference-count":44,"publisher":"American Association for Cancer Research (AACR)","issue":"3","license":[{"start":{"date-parts":[[2023,3,6]],"date-time":"2023-03-06T00:00:00Z","timestamp":1678060800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"HHS | National Institutes of Health","award":["R01 CA120206"],"award-info":[{"award-number":["R01 CA120206"]}]},{"name":"HHS | National Institutes of Health","award":["U01 CA168856"],"award-info":[{"award-number":["U01 CA168856"]}]}],"content-domain":{"domain":["aacrjournals.org"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2023,3,6]]},"abstract":"<jats:p>There is an urgent need for the identification of reliable prognostic biomarkers for patients with intrahepatic cholangiocarcinoma (iCCA) and alterations in N-glycosylation have demonstrated an immense potential to be used as diagnostic strategies for many cancers, including hepatocellular carcinoma (HCC). N-glycosylation is one of the most common post-translational modifications known to be altered based on the status of the cell. N-glycan structures on glycoproteins can be modified based on the addition or removal of specific N-glycan residues, some of which have been linked to liver diseases. However, little is known concerning the N-glycan alterations that are associated with iCCA. We characterized the N-glycan modifications quantitatively and qualitatively in three cohorts, consisting of two tissue cohorts: a discovery cohort (n = 104 cases) and a validation cohort (n = 75), and one independent serum cohort consisting of patients with iCCA, HCC, or benign chronic liver disease (n = 67). N-glycan analysis in situ was correlated to tumor regions annotated on histopathology and revealed that bisected fucosylated N-glycan structures were specific to iCCA tumor regions. These same N-glycan modifications were significantly upregulated in iCCA tissue and serum relative to HCC and bile duct disease, including primary sclerosing cholangitis (PSC) (P &amp;lt; 0.0001). N-glycan modifications identified in iCCA tissue and serum were used to generate an algorithm that could be used as a biomarker of iCCA. We demonstrate that this biomarker algorithm quadrupled the sensitivity (at 90% specificity) of iCCA detection as compared with carbohydrate antigen 19-9, the current \u201cgold standard\u201d biomarker of CCA.<\/jats:p>\n                  <jats:sec>\n                    <jats:title>Significance:<\/jats:title>\n                    <jats:p>This work elucidates the N-glycan alterations that occur directly in iCCA tissue and utilizes this information to discover serum biomarkers that can be used for the noninvasive detection of iCCA.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1158\/2767-9764.crc-22-0422","type":"journal-article","created":{"date-parts":[[2023,2,13]],"date-time":"2023-02-13T09:35:35Z","timestamp":1676280935000},"page":"383-394","update-policy":"https:\/\/doi.org\/10.1158\/crossmark_policy","source":"Crossref","is-referenced-by-count":13,"title":["Analysis of N-linked Glycan Alterations in Tissue and Serum Reveals Promising Biomarkers for Intrahepatic Cholangiocarcinoma"],"prefix":"10.1158","volume":"3","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-0091-2355","authenticated-orcid":true,"given":"Shaaron","family":"Ochoa-Rios","sequence":"first","affiliation":[{"name":"1Department of Cell and Molecular Pharmacology, Medical University of South Carolina, Charleston, South Carolina."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3988-6817","authenticated-orcid":true,"given":"Calvin R.K.","family":"Blaschke","sequence":"additional","affiliation":[{"name":"1Department of Cell and Molecular Pharmacology, Medical University of South Carolina, Charleston, South Carolina."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3001-3569","authenticated-orcid":true,"given":"Mengjun","family":"Wang","sequence":"additional","affiliation":[{"name":"1Department of Cell and Molecular Pharmacology, Medical University of South Carolina, Charleston, South Carolina."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9151-1188","authenticated-orcid":true,"given":"Kendell D.","family":"Peterson","sequence":"additional","affiliation":[{"name":"2Department of Pediatrics, Medical University of South Carolina, Charleston, South Carolina."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0280-1445","authenticated-orcid":true,"given":"Andrew","family":"DelaCourt","sequence":"additional","affiliation":[{"name":"1Department of Cell and Molecular Pharmacology, Medical University of South Carolina, Charleston, South Carolina."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7524-258X","authenticated-orcid":true,"given":"St\u00e9phane Elie","family":"Grauzam","sequence":"additional","affiliation":[{"name":"1Department of Cell and Molecular Pharmacology, Medical University of South Carolina, Charleston, South Carolina."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0531-6018","authenticated-orcid":true,"given":"David","family":"Lewin","sequence":"additional","affiliation":[{"name":"3Department of Pathology and Laboratory Medicine, Medical University of South Carolina, Charleston, South Carolina."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4436-555X","authenticated-orcid":true,"given":"Peggi","family":"Angel","sequence":"additional","affiliation":[{"name":"1Department of Cell and Molecular Pharmacology, Medical University of South Carolina, Charleston, South Carolina."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7885-8574","authenticated-orcid":true,"given":"Lewis R.","family":"Roberts","sequence":"additional","affiliation":[{"name":"4Division of Gastroenterology and Hepatology, Mayo Clinic, Rochester, Minnesota."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6285-6440","authenticated-orcid":true,"given":"Richard","family":"Drake","sequence":"additional","affiliation":[{"name":"1Department of Cell and Molecular Pharmacology, Medical University of South Carolina, Charleston, South Carolina."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9846-9389","authenticated-orcid":true,"given":"Anand S.","family":"Mehta","sequence":"additional","affiliation":[{"name":"1Department of Cell and Molecular Pharmacology, Medical University of South Carolina, Charleston, South Carolina."}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1086","published-online":{"date-parts":[[2023,3,6]]},"reference":[{"key":"2023030614022662100_","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1007\/s11894-008-0008-9","article-title":"Diagnosis and management of cholangiocarcinoma","volume":"10","author":"Sandhu","year":"2008","journal-title":"Curr Gastroenterol Rep"},{"key":"2023030614022662100_","doi-asserted-by":"crossref","first-page":"158","DOI":"10.32074\/1591-951X-252","article-title":"Cholangiocarcinoma","volume":"113","author":"Sarcognato","year":"2021","journal-title":"Pathologica"},{"key":"2023030614022662100_","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1038\/s41572-021-00300-2","article-title":"Cholangiocarcinoma","volume":"7","author":"Brindley","year":"2021","journal-title":"Nat Rev Dis Primers"},{"key":"2023030614022662100_","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1016\/B978-1-4160-5766-6.00019-4","article-title":"Immunohistology of the pancreas, biliary tract, and liver","author":"Basturk","year":"2011","journal-title":"Diagnostic immunohistochem [Internet]"},{"key":"2023030614022662100_","doi-asserted-by":"crossref","first-page":"13","DOI":"10.2147\/IJGM.S186854","article-title":"Cholangiocarcinoma: a guide for the nonspecialist","volume":"12","author":"Alsaleh","year":"2019","journal-title":"Int J Gen Med"},{"key":"2023030614022662100_","article-title":"N-glycans","volume-title":"Essentials of glycobiology","author":"Stanley","year":"2017","edition":"3rd ed"},{"key":"2023030614022662100_","doi-asserted-by":"crossref","first-page":"2749","DOI":"10.1002\/elps.201700084","article-title":"Serum N-glycans outperform CA19\u20139 in diagnosis of extrahepatic cholangiocarcinoma","volume":"38","author":"Wang","year":"2017","journal-title":"Electrophoresis"},{"key":"2023030614022662100_","first-page":"1030","article-title":"Increased expression of the high-mannose M6N2 and NeuAc3H3N3M3N2F tri-antennary N-glycansin cholangiocarcinoma","volume":"15","author":"Talabnin","year":"2018","journal-title":"Oncol Lett"},{"key":"2023030614022662100_","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1002\/cjp2.136","article-title":"Plasma proteome plus site-specific N-glycoprofiling for hepatobiliary carcinomas","volume":"5","author":"Chang","year":"2019","journal-title":"J Pathol Clin Res"},{"key":"2023030614022662100_","article-title":"Glycosyltransferases and glycan-processing enzymes","volume-title":"Essentials of glycobiology","author":"RJ","year":"2017","edition":"3rd ed"},{"key":"2023030614022662100_","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1002\/pmic.201300387","article-title":"Cell surface protein glycosylation in cancer","volume":"14","author":"Christiansen","year":"2014","journal-title":"Proteomics"},{"key":"2023030614022662100_","doi-asserted-by":"crossref","first-page":"3284","DOI":"10.1002\/pmic.200800163","article-title":"Evaluation of the serum N-linked glycome for the diagnosis of cancer and chronic inflammation","volume":"8","author":"Arnold","year":"2008","journal-title":"Proteomics"},{"key":"2023030614022662100_","doi-asserted-by":"crossref","first-page":"10231","DOI":"10.1073\/pnas.172380699","article-title":"Glycosylation defining cancer malignancy: New wine in an old bottle","volume":"99","author":"Hakomori","year":"2002","journal-title":"Proc Natl Acad Sci U S A"},{"key":"2023030614022662100_","doi-asserted-by":"crossref","first-page":"1241","DOI":"10.3390\/cancers11091241","article-title":"The diverse contributions of fucose linkages in cancer","volume":"11","author":"Keeley","year":"2019","journal-title":"Cancers"},{"key":"2023030614022662100_","doi-asserted-by":"crossref","first-page":"3454","DOI":"10.1021\/acs.jproteome.8b00323","article-title":"N-linked glycan branching and fucosylation are increased directly in hcc tissue as determined through in situ glycan imaging","volume":"17","author":"West","year":"2018","journal-title":"J Proteome Res"},{"key":"2023030614022662100_","doi-asserted-by":"crossref","first-page":"592","DOI":"10.1016\/j.jhep.2008.12.010","article-title":"Alteration of protein glycosylation in liver diseases","volume":"50","author":"Blomme","year":"2009","journal-title":"J Hepatol"},{"key":"2023030614022662100_","doi-asserted-by":"crossref","first-page":"823","DOI":"10.1373\/clinchem.2009.139295","article-title":"Diagnostic value of the hemopexin n-glycan profile in hepatocellular carcinoma patients","volume":"56","author":"Debruyne","year":"2010","journal-title":"Clin Chem"},{"key":"2023030614022662100_","doi-asserted-by":"crossref","first-page":"1426","DOI":"10.1002\/hep.21855","article-title":"N-glycomic changes in hepatocellular carcinoma patients with liver cirrhosis induced by hepatitis B virus","volume":"46","author":"Liu","year":"2007","journal-title":"Hepatology"},{"key":"2023030614022662100_","doi-asserted-by":"crossref","first-page":"5388","DOI":"10.1021\/acs.jproteome.5b00792","article-title":"ESI-LC-MS method for haptoglobin fucosylation analysis in hepatocellular carcinoma and liver cirrhosis","volume":"14","author":"Zhang","year":"2015","journal-title":"J Proteome Res"},{"key":"2023030614022662100_","doi-asserted-by":"crossref","first-page":"4932","DOI":"10.1021\/acs.jproteome.5b00662","article-title":"Mass spectrometric N-glycan analysis of haptoglobin from patient serum samples using a 96-well plate format","volume":"14","author":"Zhu","year":"2015","journal-title":"J Proteome Res"},{"key":"2023030614022662100_","doi-asserted-by":"crossref","first-page":"2986","DOI":"10.1021\/pr500128t","article-title":"Analysis of serum haptoglobin fucosylation in hepatocellular carcinoma and liver cirrhosis of different etiologies","volume":"13","author":"Zhu","year":"2014","journal-title":"J Proteome Res"},{"key":"2023030614022662100_","doi-asserted-by":"crossref","first-page":"2887","DOI":"10.1021\/pr500043k","article-title":"Mass-selected site-specific core-fucosylation of ceruloplasmin in alcohol-related hepatocellular carcinoma","volume":"13","author":"Yin","year":"2014","journal-title":"J Proteome Res"},{"key":"2023030614022662100_","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1016\/j.cll.2021.03.005","article-title":"Glycan imaging mass spectrometry: progress in developing clinical diagnostic assays for tissues, biofluids, and cells","volume":"41","author":"Blaschke","year":"2021","journal-title":"Clin Lab Med"},{"key":"2023030614022662100_","doi-asserted-by":"crossref","first-page":"674","DOI":"10.1002\/mas.21725","article-title":"Applications and continued evolution of glycan imaging mass spectrometry","volume":"42","author":"McDowell","year":"2021","journal-title":"Mass Spectrom Rev"},{"key":"2023030614022662100_","doi-asserted-by":"crossref","first-page":"e68","DOI":"10.1002\/cpps.68","article-title":"In situ imaging of N-glycans by MALDI imaging mass spectrometry of fresh or formalin-fixed paraffin-embedded tissue","volume":"94","author":"Drake","year":"2018","journal-title":"Curr Protoc Protein Sci"},{"key":"2023030614022662100_","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1016\/bs.acr.2016.11.009","article-title":"MALDI mass spectrometry imaging of N-linked glycans in cancer tissues","volume":"134","author":"Drake","year":"2017","journal-title":"Adv Cancer Res"},{"key":"2023030614022662100_","doi-asserted-by":"crossref","first-page":"2989","DOI":"10.1021\/acs.jproteome.0c00024","article-title":"New enzymatic approach to distinguish fucosylation isomers of N-linked glycans in tissues using MALDI imaging mass spectrometry","volume":"19","author":"West","year":"2020","journal-title":"J Proteome Res"},{"key":"2023030614022662100_","doi-asserted-by":"crossref","first-page":"2511","DOI":"10.1021\/jasms.0c00213","article-title":"Rapid N-glycan profiling of serum and plasma by a novel slide-based imaging mass spectrometry workflow","volume":"31","author":"Blaschke","year":"2020","journal-title":"J Am Soc Mass Spectrom"},{"key":"2023030614022662100_","doi-asserted-by":"crossref","DOI":"10.1007\/978-1-4939-2343-4","volume-title":"Glycoinformatics","author":"L\u00fctteke","year":"2015","edition":"2015th ed."},{"key":"2023030614022662100_","doi-asserted-by":"crossref","first-page":"100012","DOI":"10.1074\/mcp.RA120.002256","article-title":"Imaging mass spectrometry and lectin analysis of n-linked glycans in carbohydrate antigen-defined pancreatic cancer tissues","volume":"20","author":"McDowell","year":"2021","journal-title":"Mol Cell Proteomics"},{"key":"2023030614022662100_","doi-asserted-by":"crossref","DOI":"10.1007\/978-1-4614-6849-3","volume-title":"Applied predictive modeling","author":"Kuhn","year":"2013"},{"key":"2023030614022662100_","article-title":"Tanglegrams are misleading for visual evaluation of tree congruencele","author":"de Vienne","year":"2018"},{"key":"2023030614022662100_","doi-asserted-by":"crossref","DOI":"10.1007\/978-3-319-71404-2","volume-title":"Numerical ecology with R","author":"Borcard","year":"2018"},{"key":"2023030614022662100_","doi-asserted-by":"crossref","first-page":"779","DOI":"10.1073\/pnas.0408928102","article-title":"Use of targeted glycoproteomics to identify serum glycoproteins that correlate with liver cancer in woodchucks and humans","volume":"102","author":"Block","year":"2005","journal-title":"Proc Natl Acad Sci U S A"},{"key":"2023030614022662100_","doi-asserted-by":"crossref","first-page":"1330","DOI":"10.1054\/bjoc.2000.1441","article-title":"Structures of disease-specific serum alpha-fetoprotein isoforms","volume":"83","author":"Johnson","year":"2000","journal-title":"Br J Cancer"},{"key":"2023030614022662100_","doi-asserted-by":"crossref","first-page":"1188","DOI":"10.1038\/sj.bjc.6690828","article-title":"Glycan composition of serum alpha-fetoprotein in patients with hepatocellular carcinoma and non-seminomatous germ cell tumour","volume":"81","author":"Johnson","year":"1999","journal-title":"Br J Cancer"},{"key":"2023030614022662100_","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1002\/prca.201600141","article-title":"Identification of fucosylated Fetuin-A as a potential biomarker for cholangiocarcinoma","volume":"11","author":"Betesh","year":"2017","journal-title":"Proteomics \u2013 Clin Appl"},{"key":"2023030614022662100_","doi-asserted-by":"crossref","first-page":"1187","DOI":"10.1002\/elps.202000392","article-title":"Serum N-glycan fingerprint helps to discriminate intrahepatic cholangiocarcinoma from hepatocellular carcinoma","volume":"42","author":"Huang","year":"2021","journal-title":"Electrophoresis"},{"key":"2023030614022662100_","doi-asserted-by":"crossref","first-page":"540","DOI":"10.1038\/nrc3982","article-title":"Glycosylation in cancer: mechanisms and clinical implications","volume":"15","author":"Pinho","year":"2015","journal-title":"Nat Rev Cancer"},{"key":"2023030614022662100_","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1038\/73163","article-title":"Suppression of tumor growth and metastasis in Mgat5-deficient mice","volume":"6","author":"Granovsky","year":"2000","journal-title":"Nat Med"},{"key":"2023030614022662100_","doi-asserted-by":"crossref","first-page":"944","DOI":"10.1002\/hep.510280408","article-title":"Gene expression of \u03b11\u20136 fucosyltransferase in human hepatoma tissues: a possible implication for increased fucosylation of \u03b1-fetoprotein","volume":"28","author":"Noda","year":"1998","journal-title":"Hepatology"},{"key":"2023030614022662100_","doi-asserted-by":"crossref","first-page":"61199","DOI":"10.18632\/oncotarget.11284","article-title":"Comprehensive N-glycan profiles of hepatocellular carcinoma reveal association of fucosylation with tumor progression and regulation of FUT8 by microRNAs","volume":"7","author":"Cheng","year":"2016","journal-title":"Oncotarget"},{"key":"2023030614022662100_","doi-asserted-by":"crossref","first-page":"100225","DOI":"10.1016\/j.mcpro.2022.100225","article-title":"Imaging mass spectrometry reveals alterations in N-linked glycosylation that are associated with histopathological changes in non-alcoholic steatohepatitis in mouse and human","volume":"21","author":"Ochoa-Rios","year":"2022","journal-title":"Mol Cell Proteomics"},{"key":"2023030614022662100_","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1186\/s13058-017-0904-8","article-title":"FUT8 promotes breast cancer cell invasiveness by remodeling TGF-\u03b2 receptor core fucosylation","volume":"19","author":"Tu","year":"2017","journal-title":"Breast Cancer Res"}],"container-title":["Cancer Research Communications"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/aacrjournals.org\/cancerrescommun\/article-pdf\/doi\/10.1158\/2767-9764.CRC-22-0422\/3269214\/crc-22-0422.pdf","content-type":"application\/pdf","content-version":"am","intended-application":"syndication"},{"URL":"https:\/\/aacrjournals.org\/cancerrescommun\/article-pdf\/3\/3\/383\/3280493\/crc-22-0422.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/aacrjournals.org\/cancerrescommun\/article-pdf\/3\/3\/383\/3280493\/crc-22-0422.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,12,6]],"date-time":"2023-12-06T15:07:37Z","timestamp":1701875257000},"score":1,"resource":{"primary":{"URL":"https:\/\/aacrjournals.org\/cancerrescommun\/article\/3\/3\/383\/718585\/Analysis-of-N-linked-Glycan-Alterations-in-Tissue"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,3,6]]},"references-count":44,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2023,3,6]]}},"URL":"https:\/\/doi.org\/10.1158\/2767-9764.crc-22-0422","relation":{"has-preprint":[{"id-type":"doi","id":"10.1158\/2767-9764.22546708.v1","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/2767-9764.c.6551233.v1","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/2767-9764.22546708","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/2767-9764.22546720.v1","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/2767-9764.22546723.v1","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/2767-9764.22546726.v1","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/2767-9764.22546714","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/2767-9764.22546711","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/2767-9764.22546723","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/2767-9764.22546717","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/2767-9764.22546726","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/2767-9764.22546711.v1","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/2767-9764.22546720","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/2767-9764.22546717.v1","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/2767-9764.c.6551233","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/2767-9764.22546714.v1","asserted-by":"object"}]},"ISSN":["2767-9764"],"issn-type":[{"value":"2767-9764","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,3,6]]}}}